Comparison between Omnitech Engineering IPO and Sudeep Pharma IPO.
Omnitech Engineering IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Sudeep Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Omnitech Engineering IPO is up to ₹583.00 Cr whereas the issue size of the Sudeep Pharma IPO is up to ₹895.00 Cr. The final issue price of Omnitech Engineering IPO is ₹227.00 per share and of Sudeep Pharma IPO is ₹593.00 per share.
| Omnitech Engineering IPO | Sudeep Pharma IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹1 per share |
| Issue Price (Lower) | ₹216.00 per share | ₹563.00 per share |
| Issue Price (Upper) | ₹227.00 per share | ₹593.00 per share |
| Issue Price (Final) | ₹227.00 per share | ₹593.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹11.00 per share | |
| Market Lot Size | 66 shares | 25 shares |
| Fresh Issue Size | 1,84,16,340 shares | 16,02,023 shares |
| Fresh Issue Size (Amount) | up to ₹418.01 Cr | up to ₹95.00 Cr |
| OFS Issue Size | 72,68,722 shares | 1,34,90,726 shares |
| OFS Issue Size (Amount) | up to ₹164.99 Cr | up to ₹800.00 Cr |
| Issue Size Total | 2,56,85,062 shares | 1,50,92,749 shares |
| Issue Size Total (Amount) | up to ₹583.00 Cr | up to ₹895.00 Cr |
Omnitech Engineering IPO opens on Feb 25, 2026, while Sudeep Pharma IPO opens on Nov 21, 2025. The closing date of Omnitech Engineering IPO and Sudeep Pharma IPO is Feb 27, 2026, and Nov 25, 2025, respectively.
| Omnitech Engineering IPO | Sudeep Pharma IPO | |
|---|---|---|
| Anchor Bid Date | Feb 24, 2026 | Nov 20, 2025 |
| Issue Open | Feb 25, 2026 | Nov 21, 2025 |
| Issue Close | Feb 27, 2026 | Nov 25, 2025 |
| Basis Of Allotment (Tentative) | Mar 02, 2026 | Nov 26, 2025 |
| Initiation of Refunds (Tentative) | Mar 04, 2026 | Nov 27, 2025 |
| Credit of Share (Tentative) | Mar 04, 2026 | Nov 27, 2025 |
| Listing date (Tentative) | Mar 05, 2026 | Nov 28, 2025 |
| Anchor Lockin End date 1 | Mar 31, 2026 | Dec 26, 2025 |
| Anchor Lockin End date 2 | May 30, 2026 | Feb 24, 2026 |
Omnitech Engineering IPO P/E ratio is 54.47, as compared to Sudeep Pharma IPO P/E ratio of 47.61.
| Omnitech Engineering IPO | Sudeep Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)Sudeep Pharma Ltd.'s revenue increased by 10% and profit after tax (PAT) rose by 4% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 94.08 | 89.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 74.19 | 76.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 54.47 | 47.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹2807.17 Cr. | ₹6697.85 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 21.55% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 16.08% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.60 | 0.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.17 | ₹12.46 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 21.46% | 27.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Omnitech Engineering IPO Retail Individual Investors (RII) are offered 89,73,569 shares while in Sudeep Pharma IPO retail investors are offered 89,73,569 shares. Qualified Institutional Buyers (QIB) are offered 51,27,753 shares in Omnitech Engineering IPO and 30,18,550 shares in Sudeep Pharma IPO.
| Omnitech Engineering IPO | Sudeep Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 76,91,629 shares | 45,27,823 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 51,27,753 shares | 30,18,550 shares |
| NII | 38,45,815 shares | 22,63,913 shares |
| RII | 89,73,569 shares | 52,82,463 shares |
| Employee | 46,296 shares | 0 shares |
| Others | ||
| Total | 2,56,85,062 shares | 1,50,92,749 shares |
Omnitech Engineering IPO subscribed 1.20x in total, whereas Sudeep Pharma IPO subscribed 93.71x.
| Omnitech Engineering IPO | Sudeep Pharma IPO | |
|---|---|---|
| QIB (times) | 3.00x | 213.08x |
| NII (times) | 0.77x | 116.72x |
| Big NII (times) | 0.74x | 134.91x |
| Small NII (times) | 0.82x | 80.33x |
| RII (times) | 0.35x | 15.65x |
| Employee (times) | 4.47x | |
| Other (times) | ||
| Total (times) | 1.20x | 93.71x |
